rxstat › Shortages › Eslicarbazepine

Eslicarbazepine shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Eslicarbazepine is anticipated but not yet confirmed. 3 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 of 4
Reports on file
10

Reports by product

Anticipated
APTIOM
600MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426889 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Anticipated
APTIOM
400MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426870 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Anticipated
APTIOM
200MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426862 · ended Jun 30, 2026 · Other (Please describe in comments)
To be discontinued
APTIOM
400MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426870
To be discontinued
APTIOM
800MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426897
To be discontinued
APTIOM
600MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426889
To be discontinued
APTIOM
200MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426862
Avoided
APTIOM
800MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426897 · ended Oct 28, 2024 · Delay in shipping of the drug.
Avoided
APTIOM
200MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426862 · ended May 30, 2024 · Delay in shipping of the drug.
Resolved
APTIOM
400MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426870 · ended Apr 15, 2024 · Delay in shipping of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Eslicarbazepine to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Eslicarbazepine is classified under “ANTIEPILEPTICS” (ATC N03AF).

Recent changes

Common questions

When will Eslicarbazepine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Eslicarbazepine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiepileptics)

Partial shortageBrivaracetam1 of 8 reported products affected · est. return Apr 3, 2026Partial shortageCarbamazepine2 of 20 reported products affected · est. return Jun 26, 2026Partial shortageClonazepam5 of 21 reported products affectedPartial shortageLacosamide6 of 34 reported products affected · est. return Aug 10, 2026Partial shortageLevetiracetam13 of 48 reported products affected · est. return Sep 11, 2026Partial shortageOxcarbazepine3 of 8 reported products affected · est. return Dec 30, 2022

All antiepileptics shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.